Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation.
Reduced fecal GABA levels in multiple sclerosis patients.
Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology.
A mouse model for testing remyelinating therapies.
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
An update on the causes, assessment and management of third division sensory trigeminal neuropathies.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Commentary.
Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.
Comparison of Percutaneous Retrograsserian Balloon Compression and Gamma Knife Radiosurgery for the Treatment of Trigeminal Neuralgia in Multiple Sclerosis: A Clinical Research Study Article.
Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60.
Effects of Proton and Combined Proton and (56)Fe Radiation on the Hippocampus.
Acute axonal damage in three different murine models of multiple sclerosis: a comparative approach.
Dihydroorotate dehydrogenase: A drug target for the development of antimalarials.
Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis.
Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.
[MEDICAL CANNABIS].
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients.
Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study.
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.
Evaluation of Handwriting Movement Kinematics: From an Ecological to a Magnetic Resonance Environment.
Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis.
Multiple sclerosis lesion in the medulla oblongata in a patient with takotsubo cardiomyopathy.

Pages